🇺🇸 FDA
Patent

US 8383580

Methods of administering lipocalins to treat metabolic disorders and cardiovascular diseases

granted A61KA61K38/17A61K38/1709

Quick answer

US patent 8383580 (Methods of administering lipocalins to treat metabolic disorders and cardiovascular diseases) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Feb 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Grant date
Tue Feb 26 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K38/17, A61K38/1709, A61P, A61P3/10